Prostacyclin analogs (eg, treprostinil, epoprostenol), endothelin antagonists (eg, bosentan), and phosphodiesterase-5 inhibitors (eg, sildenafil, tadalafil) have been shown to improve performance on 6-minute walk tests and to reduce N-terminal pro-brain natriuretic peptide (NT-proBNP) levels.